Steven Kho1, Labibah Qotrunnada2, Leo Leonardo3, Benediktus Andries3, Putu A I Wardani4, Aurelie Fricot5, Benoit Henry5, David Hardy6, Nur I Margyaningsih2, Dwi Apriyanti2, Agatha M Puspitasari2, Pak Prayoga3, Leily Trianty2, Enny Kenangalem3,4, Fabrice Chretien6, Valentine Brousse5, Innocent Safeukui7, Hernando A Del Portillo8,9,10, Carmen Fernandez-Becerra8,9, Elamaran Meibalan11,12, Matthias Marti11,13, Ric N Price1,14,15, Tonia Woodberry1, Papa A Ndour5, Bruce M Russell16, Tsin W Yeo1, Gabriela Minigo1, Rintis Noviyanti2, Jeanne R Poespoprodjo3,4,17, Nurjati C Siregar2,18, Pierre A Buffet5, Nicholas M Anstey1. 1. Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia. 2. Eijkman Institute for Molecular Biology, Jakarta, Indonesia. 3. Timika Malaria Research Program, Papuan Health and Community Development Foundation, Timika, Papua, Indonesia. 4. Rumah Sakit Umum Daerah Kabupaten Mimika, Timika, Papua, Indonesia. 5. UMR_S1134, BIGR, Inserm, Université de F-75015 Paris, and Laboratory of Excellence GR-Ex, Paris, France. 6. Institut Pasteur, Experimental Neuropathology Unit, Paris, France. 7. Department of Biological Sciences, Notre Dame University, Notre Dame, Indiana, United States of America. 8. ISGlobal, Hospital Clinic-Universitat de Barcelona, Barcelona, Spain. 9. Germans Trias I Pujol Research Institute, Badalona, Spain. 10. Catalan Institution for Research and Advanced Studies, Barcelona, Spain. 11. Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America. 12. Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America. 13. Wellcome Center for Integrative Parasitology, University of Glasgow, Glasgow, United Kingdom. 14. Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. 15. Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. 16. Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand. 17. Department of Pediatrics, University of Gadjah Mada, Yogyakarta, Indonesia. 18. Department of Anatomical Pathology, Rumah Sakit Cipto Mangunkusumo and Universitas Indonesia, Jakarta, Indonesia.
Abstract
BACKGROUND: A very large biomass of intact asexual-stage malaria parasites accumulates in the spleen of asymptomatic human individuals infected with Plasmodium vivax. The mechanisms underlying this intense tropism are not clear. We hypothesised that immature reticulocytes, in which P. vivax develops, may display high densities in the spleen, thereby providing a niche for parasite survival. METHODS AND FINDINGS: We examined spleen tissue in 22 mostly untreated individuals naturally exposed to P. vivax and Plasmodium falciparum undergoing splenectomy for any clinical indication in malaria-endemic Papua, Indonesia (2015 to 2017). Infection, parasite and immature reticulocyte density, and splenic distribution were analysed by optical microscopy, flow cytometry, and molecular assays. Nine non-endemic control spleens from individuals undergoing spleno-pancreatectomy in France (2017 to 2020) were also examined for reticulocyte densities. There were no exclusion criteria or sample size considerations in both patient cohorts for this demanding approach. In Indonesia, 95.5% (21/22) of splenectomy patients had asymptomatic splenic Plasmodium infection (7 P. vivax, 13 P. falciparum, and 1 mixed infection). Significant splenic accumulation of immature CD71 intermediate- and high-expressing reticulocytes was seen, with concentrations 11 times greater than in peripheral blood. Accordingly, in France, reticulocyte concentrations in the splenic effluent were higher than in peripheral blood. Greater rigidity of reticulocytes in splenic than in peripheral blood, and their higher densities in splenic cords both suggest a mechanical retention process. Asexual-stage P. vivax-infected erythrocytes of all developmental stages accumulated in the spleen, with non-phagocytosed parasite densities 3,590 times (IQR: 2,600 to 4,130) higher than in circulating blood, and median total splenic parasite loads 81 (IQR: 14 to 205) times greater, accounting for 98.7% (IQR: 95.1% to 98.9%) of the estimated total-body P. vivax biomass. More reticulocytes were in contact with sinus lumen endothelial cells in P. vivax- than in P. falciparum-infected spleens. Histological analyses revealed 96% of P. vivax rings/trophozoites and 46% of schizonts colocalised with 92% of immature reticulocytes in the cords and sinus lumens of the red pulp. Larger splenic cohort studies and similar investigations in untreated symptomatic malaria are warranted. CONCLUSIONS: Immature CD71+ reticulocytes and splenic P. vivax-infected erythrocytes of all asexual stages accumulate in the same splenic compartments, suggesting the existence of a cryptic endosplenic lifecycle in chronic P. vivax infection. Findings provide insight into P. vivax-specific adaptions that have evolved to maximise survival and replication in the spleen.
BACKGROUND: A very large biomass of intact asexual-stage malaria parasites accumulates in the spleen of asymptomatic human individuals infected with Plasmodium vivax. The mechanisms underlying this intense tropism are not clear. We hypothesised that immature reticulocytes, in which P. vivax develops, may display high densities in the spleen, thereby providing a niche for parasite survival. METHODS AND FINDINGS: We examined spleen tissue in 22 mostly untreated individuals naturally exposed to P. vivax and Plasmodium falciparum undergoing splenectomy for any clinical indication in malaria-endemic Papua, Indonesia (2015 to 2017). Infection, parasite and immature reticulocyte density, and splenic distribution were analysed by optical microscopy, flow cytometry, and molecular assays. Nine non-endemic control spleens from individuals undergoing spleno-pancreatectomy in France (2017 to 2020) were also examined for reticulocyte densities. There were no exclusion criteria or sample size considerations in both patient cohorts for this demanding approach. In Indonesia, 95.5% (21/22) of splenectomy patients had asymptomatic splenic Plasmodiuminfection (7 P. vivax, 13 P. falciparum, and 1 mixed infection). Significant splenic accumulation of immature CD71 intermediate- and high-expressing reticulocytes was seen, with concentrations 11 times greater than in peripheral blood. Accordingly, in France, reticulocyte concentrations in the splenic effluent were higher than in peripheral blood. Greater rigidity of reticulocytes in splenic than in peripheral blood, and their higher densities in splenic cords both suggest a mechanical retention process. Asexual-stage P. vivax-infected erythrocytes of all developmental stages accumulated in the spleen, with non-phagocytosed parasite densities 3,590 times (IQR: 2,600 to 4,130) higher than in circulating blood, and median total splenic parasite loads 81 (IQR: 14 to 205) times greater, accounting for 98.7% (IQR: 95.1% to 98.9%) of the estimated total-body P. vivax biomass. More reticulocytes were in contact with sinus lumen endothelial cells in P. vivax- than in P. falciparum-infected spleens. Histological analyses revealed 96% of P. vivax rings/trophozoites and 46% of schizonts colocalised with 92% of immature reticulocytes in the cords and sinus lumens of the red pulp. Larger splenic cohort studies and similar investigations in untreated symptomatic malaria are warranted. CONCLUSIONS: Immature CD71+ reticulocytes and splenic P. vivax-infected erythrocytes of all asexual stages accumulate in the same splenic compartments, suggesting the existence of a cryptic endosplenic lifecycle in chronic P. vivax infection. Findings provide insight into P. vivax-specific adaptions that have evolved to maximise survival and replication in the spleen.
Authors: Rhea J Longley; Matthew J Grigg; Kael Schoffer; Thomas Obadia; Stephanie Hyslop; Kim A Piera; Narimane Nekkab; Ramin Mazhari; Eizo Takashima; Takafumi Tsuboi; Matthias Harbers; Kevin Tetteh; Chris Drakeley; Chetan E Chitnis; Julie Healer; Wai-Hong Tham; Jetsumon Sattabongkot; Michael T White; Daniel J Cooper; Giri S Rajahram; Bridget E Barber; Timothy William; Nicholas M Anstey; Ivo Mueller Journal: Cell Rep Med Date: 2022-06-21
Authors: Nicholas M Anstey; Matthew J Grigg; Giri S Rajahram; Daniel J Cooper; Timothy William; Steven Kho; Bridget E Barber Journal: Adv Parasitol Date: 2021-08-28 Impact factor: 3.125
Authors: João L Silva-Filho; João Ck Dos-Santos; Carla Judice; Dario Beraldi; Kannan Venugopal; Diogenes Lima; Helder I Nakaya; Erich V De Paula; Stefanie Cp Lopes; Marcus Vg Lacerda; Matthias Marti; Fabio Tm Costa Journal: Elife Date: 2021-09-29 Impact factor: 8.140
Authors: Stephen D Woolley; Louise Marquart; John Woodford; Stephan Chalon; Joerg J Moehrle; James S McCarthy; Bridget E Barber Journal: Malar J Date: 2021-12-20 Impact factor: 2.979